4 results  1 of 1 

1 Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
Jinxiang Huang, Fenglin Zhang, Lei Jiang, Guohan Hu, Wei Sun, Chenran Zhang, Xuehua Ding
Cancer Res Treat.2017;49(2):358-373.   Published online 2016 July 28     DOI: http://dx.doi.org/10.4143/crt.2016.017
      
2 Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
Kyung Rae Cho, Kyung-Il Jo, Hyung Jin Shin
Brain Tumor Res Treat.2013;1(2):71-77.   Published online 2013 October 31     DOI: http://dx.doi.org/10.14791/btrt.2013.1.2.71
      
3 Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report
Seong Hee Kang, Min Ja Kim, Il Young Shin, Dae Won Park, Jang Wook Sohn, Young Kyung Yoon
J Korean Med Sci.2012;27(8):965-968.   Published online 2012 July 25     DOI: http://dx.doi.org/10.3346/jkms.2012.27.8.965
      
4 Normal Repetitive Pregnancies and Tumor Regression Induced by Low-Dose Bromocriptine in a Patient with Macroprolactinoma
Hye Jung Choi, Jin Yong Park, Woo Seok Choi, Jong Gyu Song, Hee Young Kim, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi
J Korean Endocr Soc.2009;24(1):42-46.   Published online 2009 March 31     DOI: http://dx.doi.org/10.3803/jkes.2009.24.1.42
      

 1 of 1